TP53 and metastatic neoplasm: For example, KC mice expressing mutant p53 (R172H/+; KPC) or deleted p53 (KC;p53null) have a similar median survival, but KPC mice develop markedly increased metastatic disease at necropsy compared to that of KC;p53null mice [41].